Univariable analysis | Multivariable analysis | |||
---|---|---|---|---|
HR (95% CI) | P* | HR (95% CI) | P† | |
Age (years) | 0.033 | 0.421 | ||
≤60 y | 1 (Ref) | 1 (Ref) | ||
>60 y | 1.231 (1.017–1.490) | 0.033 | 1.112 (0.762–1.397) | 0.421 |
Sex | 0.816 | 0.736 | ||
Women | 1 (Ref) | 1 (Ref) | ||
Men | 1.025 (0.833–1.261) | 0.816 | 1.103 (0.836–1.207) | 0.736 |
Extranodal sites | 0.576 | 0.512 | ||
0–1 site | 1 (Ref) | 1 (Ref) | ||
More than 1 site | 1.080 (0.824–1.416) | 0.576 | 1.375 (0.831–1.454) | 0.512 |
Performance status | 0.058 | 0.062 | ||
0–1 | 1 (Ref) | 1 (Ref) | ||
2–4 | 1.755 (0.838–2.146) | 0.058 | 1.172 (0834–1.884) | 0.062 |
Clinical stage | 0.000 | 0.024 | ||
I or II | 1 (Ref) | 1 (Ref) | ||
III or IV | 1.742 (1.382–3.666) | 0.000 | 1.217 (1.114–2.371) | 0.024 |
Bulky disease >10 cm | 0.221 | 0.413 | ||
No | 1 (Ref) | 1 (Ref) | ||
Yes | 1.177 (0.591–1.529) | 0.221 | 1.124 (0.734–1.349) | 0.413 |
Evolution | 0.789 | 0.442 | ||
CR | 1 (Ref) | 1 (Ref) | ||
No CR | 0.901 (0.723–1.122) | 0.789 | 0.834 (0.644–1.176) | 0.442 |
IPI Score | 0.007 | |||
0–1 | 1 (Ref) | |||
2 | 1.236 (1.074–2.537) | 0.003 | ||
3 | 1.779 (1.362–2.778) | 0.014 | ||
4–5 | 2.343 (1.742–4.621) | 0.000 | ||
Lactate dehydrogenase | 0.011 | 0.031 | ||
Normal | 1 (Ref) | 1 (Ref) | ||
Elevated | 1.921 (1.347–3.312) | 0.011 | 1.383 (1.152–2.511) | 0.031 |
SPRR1A expression | 0.000 | 0.013 | ||
Negative | 1 (Ref) | 1 (Ref) | ||
Positive | 1.792 (1.364–3.778) | 0.000 | 1.564 (1.337–2.464) | 0.013 |